Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q56722061 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235806.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q56722061 | ||
| 024 | ‡a 0000-0003-3984-9274 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q56722061 | ||
| 100 | 0 | ‡a Eduardo Reyes-Vargas ‡c researcher ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Eduardo Reyes-Vargas ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma. | ||
| 670 | ‡a Author's Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern | ||
| 670 | ‡a Author's Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells | ||
| 670 | ‡a Author's ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides | ||
| 670 | ‡a Author's Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity | ||
| 670 | ‡a Author's HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft | ||
| 670 | ‡a Author's Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. | ||
| 670 | ‡a Author's Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs | ||
| 670 | ‡a Author's Mice completely lacking immunoproteasomes show major changes in antigen presentation | ||
| 670 | ‡a Author's Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. | ||
| 670 | ‡a Author's Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. | ||
| 670 | ‡a Author's Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides | ||
| 909 | ‡a (orcid) 0000000339849274 ‡9 1 | ||
| 919 | ‡a peptidomicanalysisoftype1diabetesassociatedhladqmoleculesandtheimpactofhladmonpeptiderepertoireediting ‡A Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. ‡9 1 | ||
| 919 | ‡a regulationofhladrpeptideoccupancybyhistonedeacetylaseinhibitors ‡A Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. ‡9 1 | ||
| 919 | ‡a type1diabetesassociatedhladq2anddq8moleculesarerelativelyresistanttohladmmediatedreleaseofinvariantchainderivedclippeptides ‡A Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides ‡9 1 | ||
| 919 | ‡a associationofantiher2antibodywithgrapheneoxideforcurativetreatmentofosteosarcoma ‡A Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma. ‡9 1 | ||
| 919 | ‡a bindingofantihlaclass1antibodytoendothelialcellsproduceaninflammatorycytokinesecretorypattern ‡A Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern ‡9 1 | ||
| 919 | ‡a endoplasmicreticulumaminopeptidaseassociatedwithantigenprocessingdefinesthecompositionandstructureofmhcclass1peptiderepertoireinnormalandvirusinfectedcells ‡A Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells ‡9 1 | ||
| 919 | ‡a eraapandtapasinindependentlyedittheaminoandcarboxylterminiofmhcclass1peptides ‡A ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides ‡9 1 | ||
| 919 | ‡a expressionofthemousemhcclassibh2t11geneproductaparalogofh2t23qa1withsharedpeptidebindingspecificity ‡A Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity ‡9 1 | ||
| 919 | ‡a hladmcatalyticallyenhancespeptidedissociationbysensingpeptidemhcclass2interactionsthroughoutthepeptidebindingcleft ‡A HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft ‡9 1 | ||
| 919 | ‡a identificationofnaturallyprocessedligandsinthec57bl6mouseusinglargescalemassspectrometricpeptidesequencingandbioinformaticsprediction ‡A Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. ‡9 1 | ||
| 919 | ‡a largescalemassspectrometricprofilingofpeptideselutedfromhlamoleculesrevealsnterminalextendedpeptidemotifs ‡A Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs ‡9 1 | ||
| 919 | ‡a micecompletelylackingimmunoproteasomesshowmajorchangesinantigenpresentation ‡A Mice completely lacking immunoproteasomes show major changes in antigen presentation ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 SUDOC|099228378 | ||
| 996 | ‡2 DNB|1056286881 | ||
| 996 | ‡2 LC|no2009161220 | ||
| 996 | ‡2 BNE|XX1099238 | ||
| 996 | ‡2 NLA|000035383363 | ||
| 996 | ‡2 SUDOC|255199953 | ||
| 996 | ‡2 NTA|289044006 | ||
| 996 | ‡2 BAV|495_191834 | ||
| 996 | ‡2 NII|DA09487527 | ||
| 996 | ‡2 NSK|000705304 | ||
| 996 | ‡2 LC|n 83015037 | ||
| 996 | ‡2 NUKAT|nx2023734049 | ||
| 996 | ‡2 LC|n 88252854 | ||
| 996 | ‡2 LC|no2013011535 | ||
| 996 | ‡2 LC|n 2020251032 | ||
| 996 | ‡2 DNB|1211861945 | ||
| 996 | ‡2 ISNI|0000000028905021 | ||
| 996 | ‡2 DNB|131802534 | ||
| 996 | ‡2 LC|no2010202492 | ||
| 996 | ‡2 BNCHL|10000000000000000109102 | ||
| 996 | ‡2 NTA|11714570X | ||
| 996 | ‡2 RERO|A000170512 | ||
| 996 | ‡2 SUDOC|061627194 | ||
| 996 | ‡2 ISNI|0000000037197258 | ||
| 996 | ‡2 NUKAT|n 2011105436 | ||
| 996 | ‡2 LC|n 95075727 | ||
| 996 | ‡2 LC|no2013122918 | ||
| 996 | ‡2 LC|n 85277389 | ||
| 996 | ‡2 ISNI|0000000401525618 | ||
| 996 | ‡2 LC|n 86022137 | ||
| 996 | ‡2 NKC|mzk2010579758 | ||
| 996 | ‡2 BNE|XX862952 | ||
| 996 | ‡2 BLBNB|001538284 | ||
| 996 | ‡2 SUDOC|156191806 | ||
| 996 | ‡2 DE633|pe51007857 | ||
| 996 | ‡2 ISNI|0000000432389399 | ||
| 996 | ‡2 DNB|130391980 | ||
| 996 | ‡2 LC|n 2014185843 | ||
| 996 | ‡2 BNF|12304131 | ||
| 996 | ‡2 LC|no2010026087 | ||
| 996 | ‡2 DNB|1202496628 | ||
| 996 | ‡2 W2Z|90406939 | ||
| 996 | ‡2 LC|no2011057757 | ||
| 996 | ‡2 ISNI|0000000072026198 | ||
| 996 | ‡2 SUDOC|119853043 | ||
| 996 | ‡2 SUDOC|150800606 | ||
| 996 | ‡2 LC|nr 90017617 | ||
| 996 | ‡2 DNB|1056527021 | ||
| 996 | ‡2 DNB|1057467855 | ||
| 996 | ‡2 BIBSYS|90406939 | ||
| 996 | ‡2 LC|no2018124159 | ||
| 996 | ‡2 ISNI|0000000050882292 | ||
| 996 | ‡2 PLWABN|9812830428405606 | ||
| 996 | ‡2 JPG|500223205 | ||
| 996 | ‡2 BLBNB|000253759 | ||
| 996 | ‡2 DNB|14196345X | ||
| 996 | ‡2 ISNI|0000000031657946 | ||
| 996 | ‡2 BAV|495_265916 | ||
| 996 | ‡2 DNB|1056682426 | ||
| 996 | ‡2 ISNI|0000000119106954 | ||
| 996 | ‡2 LC|no2023113596 | ||
| 996 | ‡2 BLBNB|001026719 | ||
| 996 | ‡2 ISNI|0000000120225205 | ||
| 996 | ‡2 DNB|104736073X | ||
| 996 | ‡2 ISNI|0000000434874718 | ||
| 996 | ‡2 SUDOC|085977136 | ||
| 996 | ‡2 N6I|vtls001274406 | ||
| 996 | ‡2 ISNI|0000000077073321 | ||
| 996 | ‡2 DNB|120671883 | ||
| 996 | ‡2 ISNI|0000000078737556 | ||
| 996 | ‡2 ISNI|0000000436054238 | ||
| 996 | ‡2 J9U|987007274418305171 | ||
| 996 | ‡2 LC|n 87921832 | ||
| 996 | ‡2 BNCHL|10000000000000000088973 | ||
| 996 | ‡2 BNCHL|10000000000000000109404 | ||
| 996 | ‡2 DNB|1056452560 | ||
| 996 | ‡2 ISNI|0000000037219234 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
